Technology areas: Biotechnology & Pharmaceuticals • Communications
3 pending office actions • 3 art units • 3 examiners • 0 of 3 (0%) have an AI response strategy ready • 1 patents granted in the last 365 days
UNIVERSITÄTSKLINIKUM HAMBURG-EPPENDORF has 3 pending office actions in Biotechnology & Pharmaceuticals. The matters involve 3 distinct examiners and 3 distinct art units, showing that the pending record is divided among separate examination assignments.
MOORE, JOHN DAVID is the busiest examiner, with 1 pending matter. The workload is not concentrated with that examiner. Each response should be developed with the particular examiner and art unit assignment in view.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| Multi-statute (no §101) | 3 (100%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MOORE, JOHN DAVID | 1 | 61.1% | +28.3% |
| LEE, YIE CHIA | 1 | 69.2% | +46.6% |
| MARCELINO HERNAND, JASMIN | 1 | — | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 3 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18719466 | LMNA GENE EXPRESSION FOR TREATMENT OF LAMINOPATHIES | MOORE, JOHN DAVID | — |
| 18684277 | ANTIGEN-BINDING POLYPEPTIDES AGAINST CD73 | LEE, YIE CHIA | — |
| 18579641 | A METHOD FOR MEASURING A PROGNOSTIC MARKER IN PROSTATE CANCER OR IN BREAST CANCER | MARCELINO HERNAND, JASMIN | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18719466 | LMNA GENE EXPRESSION FOR TREATMENT OF LAMINOPATHIES | MOORE, JOHN DAVID | — |
| 18684277 | ANTIGEN-BINDING POLYPEPTIDES AGAINST CD73 | LEE, YIE CHIA | — |
| Art Unit | Apps |
|---|---|
| 1638 | 1 |
| 1642 | 1 |
| 2676 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18719466 | LMNA GENE EXPRESSION FOR TREATMENT OF LAMINOPATHIES | MOORE, JOHN DAVID | 1638 | §102§112 | Non-Final OA | — | Pending | Jun 13, 2024 |
| 18684277 | ANTIGEN-BINDING POLYPEPTIDES AGAINST CD73 | LEE, YIE CHIA | 1642 | §103§112 | Non-Final OA | — | Pending | Feb 16, 2024 |
| 18579641 | A METHOD FOR MEASURING A PROGNOSTIC MARKER IN PROSTATE CANCER OR IN BREAST CANCER | MARCELINO HERNAND, JASMIN | 2676 | §102§103§112 | Non-Final OA | — | Pending | Jan 16, 2024 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free TrialUNIVERSITÄTSKLINIKUM HAMBURG-EPPENDORF has 3 pending office actions as of October 2026, spread across 3 art units and 3 examiners.
John David Moore has the most, with 1 of UNIVERSITÄTSKLINIKUM HAMBURG-EPPENDORF's pending office actions.
Mostly Biotechnology & Pharmaceuticals (USPTO Tech Center 1600), based on where its pending office actions are examined.
